The impact of viability assessment using myocardial perfusion imaging on patient management and outcome

Journal of Nuclear Cardiology

Volumn 17, Issue 3, 2010, Pages 378-389

  Hage, Fadi G ^a,b   Venkataraman, Rajesh ^a   Aljaroudi, Wael ^a   Bravo, Paco E ^c   McLarry, Joel ^d   Faulkner, Michael ^d   Heo, Jaekyeong ^a   Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

Coronary revascularization; Mortality; Myocardial perfusion imaging; Viability

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; SPIRONOLACTONE; THALLIUM 201; WARFARIN;

ADULT; ARTICLE; AUTOANALYSIS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; THORAX PAIN; TRANSIENT ISCHEMIC DILATATION;

CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOMYOPATHIES; CORONARY ARTERY BYPASS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PROPORTIONAL HAZARDS MODELS; RADIOISOTOPES; STROKE VOLUME; THALLIUM RADIOISOTOPES;

EID: 77953324193     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-010-9199-1     Document Type: Article

References (35)

1. Iskandrian AE, Garcia EV. Nuclear cardiac imaging: Principles and applications. Oxford: Oxford University Press; 2008.
2. D Levy S Kenchaiah MG Larson EJ Benjamin MJ Kupka KK Ho, et al. 2002 Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 1397 1402 10.1056/NEJMoa020265 12409541 (Pubitemid 35239711)
3. AF Schinkel D Poldermans JL Vanoverschelde A Elhendy E Boersma JR Roelandt, et al. 2004 Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction Am J Cardiol 93 14 17 10.1016/j.amjcard.2003.09.005 14697459 (Pubitemid 38022027)
4. P Chareonthaitawee BJ Gersh PA Araoz RJ Gibbons 2005 Revascularization in severe left ventricular dysfunction: The role of viability testing J Am Coll Cardiol 46 567 574 10.1016/j.jacc.2005.03.072 16098417 (Pubitemid 41132679)
5. AF Schinkel JJ Bax D Poldermans A Elhendy R Ferrari SH Rahimtoola 2007 Hibernating myocardium: Diagnosis and patient outcomes Curr Probl Cardiol 32 375 410 10.1016/j.cpcardiol.2007.04.001 17560992 (Pubitemid 46881171)
6. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification Am J Kidney Dis 39 S1 266 10.1016/S0272-6386(02)70081-4
7. JJ Mahmarian MD Cerqueira AE Iskandrian TM Bateman GS Thomas RC Hendel, et al. 2009 Regadenoson induces comparable left ventricular perfusion defects as adenosine: A quantitative analysis from the ADVANCE MPI 2 trial JACC Cardiovasc Imaging 2 959 968 10.1016/j.jcmg.2009.04.011 19679284
8. CL Hansen RA Goldstein OO Akinboboye DS Berman EH Botvinick KB Churchwell, et al. 2007 Myocardial perfusion and function: Single photon emission computed tomography J Nucl Cardiol 14 e39 e60 10.1016/j.nuclcard.2007. 09.023 18022099 (Pubitemid 350082592)
9. JM Canty Jr JA Fallavollita 2000 Chronic hibernation and chronic stunning: A continuum J Nucl Cardiol 7 509 527 10.1067/mnc.2000.109683 11083201
10. HW Strauss K Harrison JK Langan E Lebowitz B Pitt 1975 Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion Circulation 51 641 645 1:CAS:528:DyaE2MXhsFWnu70%3D 1116254
11. GM Pohost LM Zir RH Moore KA McKusick TE Guiney GA Beller 1977 Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201 Circulation 55 294 302 1:STN:280:DyaE2s%2FovFOmsg%3D%3D 832345
12. AP Nielsen KG Morris R Murdock FP Bruno FR Cobb 1980 Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise Circulation 61 797 801 1:STN:280:DyaL3c7jt1ylug%3D%3D 7357723
13. HF Weich HW Strauss B Pitt 1977 The extraction of thallium-201 by the myocardium Circulation 56 188 191 1:CAS:528:DyaE2sXltFeqsLk%3D 872309
14. BA Khaw HW Strauss GM Pohost JT Fallon HA Katus E Haber 1983 Relation of immediate and delayed thallium-201 distribution to localization of iodine-125 antimyosin antibody in acute experimental myocardial infarction Am J Cardiol 51 1428 1432 10.1016/0002-9149(83)90324-7 1:STN:280:DyaL3s3gtV2nuw%3D%3D 6846171
15. CA Moore J Cannon DD Watson S Kaul GA Beller 1990 Thallium 201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction Circulation 81 1622 1632 1:STN:280:DyaK3c3jsFensg%3D%3D 2331770
16. AM Grunwald DD Watson HH Holzgrefe Jr JF Irving GA Beller 1981 Myocardial thallium-201 kinetics in normal and ischemic myocardium Circulation 64 610 618 1:CAS:528:DyaL3MXlsVKiurs%3D 7261290
17. RD Okada CA Boucher 1987 Differentiation of viable and nonviable myocardium after acute reperfusion using serial thallium-201 imaging Am Heart J 113 241 250 10.1016/0002-8703(87)90260-2 1:STN:280:DyaL2s7isVehtg%3D%3D 3812178 (Pubitemid 17011277)
18. J Maddahi W Ganz K Ninomiya J Hashida MC Fishbein A Mondkar, et al. 1981 Myocardial salvage by intracoronary thrombolysis in evolving acute myocardial infarction: Evaluation using intracoronary injection of thallium-201 Am Heart J 102 664 674 10.1016/0002-8703(81)90091-0 1:CAS:528:DyaL3MXlvF2rsrY%3D 6169270 (Pubitemid 11030026)
19. GA Beller LP Budge 2009 Viable: Yes, no, or somewhere in the middle? JACC Cardiovasc Imaging 2 1069 1071 10.1016/j.jcmg.2009.06.005 19761984
20. RS Beanlands G Nichol E Huszti D Humen N Racine M Freeman, et al. 2007 F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2) J Am Coll Cardiol 50 2002 2012 10.1016/j.jacc.2007.09.006 17996568 (Pubitemid 350054917)
21. G D'Egidio G Nichol KA Williams A Guo L Garrard R deKemp, et al. 2009 Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: A substudy of the PARR-2 trial JACC Cardiovasc Imaging 2 1060 1068 10.1016/j.jcmg.2009.02.017 19761983
22. CM O'Connor EJ Velazquez LH Gardner PK Smith MF Newman KP Landolfo, et al. 2002 Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank) Am J Cardiol 90 101 107 10.1016/S0002-9149(02)02429-3 12106836 (Pubitemid 34775115)
23. KC Allman LJ Shaw R Hachamovitch JE Udelson 2002 Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis J Am Coll Cardiol 39 1151 1158 10.1016/S0735-1097(02)01726-6 11923039 (Pubitemid 34267418)
24. G Gioia J Powers J Heo AS Iskandrian 1995 Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy Am J Cardiol 75 759 762 10.1016/S0002-9149(99)80406-8 1:STN:280: DyaK2M3jtlejtg%3D%3D 7717274
25. JG Cleland DJ Pennell SG Ray AJ Coats PW Macfarlane GD Murray, et al. 2003 Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): Randomised controlled trial Lancet 362 14 21 10.1016/S0140-6736(03)13801-9 1:CAS:528:DC%2BD3sXltF2isrg%3D 12853194 (Pubitemid 36840896)
26. V Dilsizian J Narula 2009 Qualitative and quantitative scrutiny by regulatory process: Is the truth subjective or objective? JACC Cardiovasc Imaging 2 1037 1038 10.1016/j.jcmg.2009.06.001 19679295
27. JJ Bax AF Schinkel E Boersma A Elhendy V Rizzello A Maat, et al. 2004 Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis Circulation 110 II18 II22 15364832
28. JT Christenson A Bloch J Maurice F Simonet V Velebit M Schmuziger 1995 Is reoperative coronary artery bypass grafting in patients with poor left ventricular ejection fractions
29. Kron IL, Cope JT, Baker LD Jr, Spotnitz HM (1997) The risks of reoperative coronary artery bypass in chronic ischemic cardiomyopathy: Results of the CABG Patch Trial. Circulation 96:II-21-5.
30. P Nardi A Pellegrino A Scafuri D Colella C Bassano P Polisca, et al. 2009 Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction Ann Thorac Surg 87 1401 1407 10.1016/j.athoracsur.2009. 02.062 19379873
31. EL Alderman MG Bourassa LS Cohen KB Davis GG Kaiser T Killip, et al. 1990 Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study Circulation 82 1629 1646 1:STN:280: DyaK3M%2FivFyqug%3D%3D 2225367 (Pubitemid 20367965)
32. EJ Velazquez KL Lee CM O'Connor JK Oh RO Bonow GM Pohost, et al. 2007 The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial J Thorac Cardiovasc Surg 134 1540 1547 10.1016/j.jtcvs.2007.05.069 18023680 (Pubitemid 350101607)
33. AF Schinkel D Poldermans A Elhendy JJ Bax 2007 Assessment of myocardial viability in patients with heart failure J Nucl Med 48 1135 1146 10.2967/jnumed.106.038851 17574986 (Pubitemid 47052654)
34. V Rizzello D Poldermans E Biagini AF Schinkel E Boersma A Boccanelli, et al. 2009 Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: Relation to viability and improvement in left ventricular ejection fraction Heart 95 1273 1277 10.1136/hrt.2008.163972 1:STN:280:DC%2BD1Mvos1WqtQ%3D%3D 19443475
35. J Narula MS Dawson BK Singh A Amanullah ER Acio FA Chaudhry, et al. 2000 Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy J Am Coll Cardiol 36 1913 1919 10.1016/S0735-1097(00)00959-1 1:STN:280:DC%2BD3M%2FkvFWqtw%3D%3D 11092664